» Articles » PMID: 37605094

Low-dose Lipopolysaccharide Alleviates Spinal Cord Injury-induced Neuronal Inflammation by Inhibiting MicroRNA-429-mediated Suppression of PI3K/AKT/Nrf2 Signaling

Overview
Journal Mol Neurobiol
Date 2023 Aug 21
PMID 37605094
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated the impact of low-dose lipopolysaccharide (LPS) on spinal cord injury (SCI) and the potential molecular mechanism. Rats were randomly assigned to four groups: Sham, SCI, SCI + LPS, and SCI + LPS + agomir. Allen's weight-drop method was used to establish an in vivo SCI model. The Basso Bcattie Bresnahan rating scale was employed to monitor locomotor function. An in vitro SCI model was constructed by subjecting PC12 cells to oxygen and glucose deprivation/ reoxygenation (OGD/R). Enzyme-linked immunosorbent assay (ELISA) was applied for the determination interleukin (IL)-1β and IL-6. The dual luciferase reporter assay was used to validate the targeting of microRNA (miR)-429 with PI3K. Immunohistochemical staining was used to assess the expression of PI3K, phosphorylated AKT and Nrf2 proteins. The Nrf2-downstream anti-oxidative stress proteins, OH-1 and NQO1, were detected by western blot assay. MiR-429 expression was detected by fluorescence in situ hybridization and real-time quantitative reverse transcription PCR. In vitro, low-dose LPS decreased miR-429 expression, activated PI3K/AKT/Nrf2, inhibited oxidative stress and inflammation, and attenuated SCI. MiR-429 was found to target and negatively regulate PI3K. Inhibition of miR-429 suppressed low-dose LPS-mediated oxidative stress and inflammation via activation of the PI3K/AKT/Nrf2 pathway. In vivo, miR-429 was detectable in neurons. Inhibition of miR-429 blocked low-dose LPS-mediated oxidative stress and inflammation via activation of the PI3K/AKT/Nrf2 pathway. Overall, low-dose LPS was found to alleviate SCI-induced neuronal oxidative stress and inflammatory response by down-regulating miR-429 to activate the PI3K/AKT/Nrf2 pathway.

Citing Articles

MicroRNAs as Biomarkers for Metabolic Disorders in Polycystic Ovary Syndrome (PCOS): A Review.

Dymanowska I, Frankowska K, Krawczyk A, Kociuba J, Gil-Kulik P, Banaszewska B Med Sci Monit. 2024; 30:e946480.

PMID: 39709519 PMC: 11670786. DOI: 10.12659/MSM.946480.


Implantable Multifunctional Micro-Oxygen Reservoir System for Promoting Vascular-Osteogenesis via Remodeling Regenerative Microenvironment.

Rui M, Mao J, Wu H, Hui Y, Shen H, Yang Y Adv Sci (Weinh). 2024; 12(3):e2409636.

PMID: 39588553 PMC: 11744641. DOI: 10.1002/advs.202409636.


CTRP9 attenuates peripheral nerve injury-induced mechanical allodynia and thermal hyperalgesia through regulating spinal microglial polarization and neuroinflammation mediated by AdipoR1 in male mice.

Liu T, Zhang L, Mei W Cell Biol Toxicol. 2024; 40(1):91.

PMID: 39460844 PMC: 11512844. DOI: 10.1007/s10565-024-09933-x.


NeuroAiD-II (MLC901) Promoted Neurogenesis by Activating the PI3K/AKT/GSK-3β Signaling Pathway in Rat Spinal Cord Injury Models.

Anjum A, Yazid M, Daud M, Idris J, Ng A, Naicker A Biomedicines. 2024; 12(8).

PMID: 39200383 PMC: 11352105. DOI: 10.3390/biomedicines12081920.


Nrf2 Signaling Pathway: Focus on Oxidative Stress in Spinal Cord Injury.

Xiao C, Lai H, Zhou J, Liu W, Zhao M, Zhao K Mol Neurobiol. 2024; 62(2):2230-2249.

PMID: 39093381 DOI: 10.1007/s12035-024-04394-z.

References
1.
Eckert M, Martin M . Trauma: Spinal Cord Injury. Surg Clin North Am. 2017; 97(5):1031-1045. DOI: 10.1016/j.suc.2017.06.008. View

2.
Yang X, Chen S, Shao Z, Li Y, Wu H, Li X . Apolipoprotein E Deficiency Exacerbates Spinal Cord Injury in Mice: Inflammatory Response and Oxidative Stress Mediated by NF-κB Signaling Pathway. Front Cell Neurosci. 2018; 12:142. PMC: 5974465. DOI: 10.3389/fncel.2018.00142. View

3.
Cardenas D, Nieshoff E, Suda K, Goto S, Sanin L, Kaneko T . A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury. Neurology. 2013; 80(6):533-9. PMC: 3589291. DOI: 10.1212/WNL.0b013e318281546b. View

4.
Scholtes F, Brook G, Martin D . Spinal cord injury and its treatment: current management and experimental perspectives. Adv Tech Stand Neurosurg. 2012; 38:29-56. DOI: 10.1007/978-3-7091-0676-1_2. View

5.
Xu S, Wang J, Zhong J, Shao M, Jiang J, Song J . CD73 alleviates GSDMD-mediated microglia pyroptosis in spinal cord injury through PI3K/AKT/Foxo1 signaling. Clin Transl Med. 2021; 11(1):e269. PMC: 7774461. DOI: 10.1002/ctm2.269. View